Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

OxSonics Ltd.

Ultrasound-activated nanoparticles deliver drugs, repair spines

This article was originally published in Start Up

Executive Summary

One shortcoming of many cancer drugs is their limited ability to reach deep into solid tumors. OxSonics Ltd. hopes to improve on this with SonoTran, an ultrasound device that activates sono-sensitive nanoparticles to push drug molecules deeper into tumors.

Advertisement

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

SC092598

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel